CytomX Shares Jump After Q1 Beat, 'Positive' Interim Trial Data

In This Article:

CytomX Therapeutics (CTMX) shares more than doubled in recent Monday trading after it reported bette

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.